Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sequent Scientific Limited ( (IN:SEQUENT) ) has shared an update.
Sequent Scientific Limited has announced a merger scheme involving several companies, including Symed Labs Limited and Viyash Life Sciences Private Limited. The National Company Law Tribunal (NCLT) has sanctioned this scheme, and a share exchange ratio has been established, where Viyash will issue 47 equity shares for every 1 equity share of Geninn Life Sciences Private Limited. This merger is expected to consolidate operations and enhance market positioning for the involved entities.
More about Sequent Scientific Limited
Sequent Scientific Limited operates in the life sciences industry, focusing on pharmaceuticals and related services. The company is involved in the development, manufacturing, and marketing of pharmaceutical products, catering to various market needs.
Average Trading Volume: 109,416
Technical Sentiment Signal: Buy
Current Market Cap: 60.34B INR
Learn more about SEQUENT stock on TipRanks’ Stock Analysis page.